Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sodium valproate 100mg suppositories
0408010W0AAARAR
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 10mg/5ml oral solution
0408010W0AABMBM
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 125mg/5ml oral solution
0408010W0AABJBJ
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 1g/10ml solution for injection ampoules
0408010W0AABUBU
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 200mg/ml oral solution
0408010W0AACACA
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 20mg/5ml oral solution
0408010W0AABKBK
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 600mg/5ml oral solution
0408010W0AABEBE
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 60mg/5ml oral solution
0408010W0AABIBI
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 60mg/5ml oral suspension
0408010W0AACBCB
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 75mg/5ml oral solution
0408010W0AABLBL
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sodium valproate 90mg/5ml oral solution
0408010W0AABFBF
|
Sodium valproate | Sodium valproate | Central Nervous System | No data available |
|
Sofonac 10mg/5mg modified-release tablets
0407020AFBEAAAA
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sofonac 20mg/10mg modified-release tablets
0407020AFBEABAB
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Sofonac 40mg/20mg modified-release tablets
0407020AFBEACAD
|
Sofonac | Oxycodone hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Solpadeine Headache tablets
0407010U0BDAAAA
|
Solpadeine Headache | Paracetamol and caffeine | Central Nervous System | No data available |
|
Somnite 2.5mg/5ml oral suspension
0401010R0BFAAAA
|
Somnite | Nitrazepam | Central Nervous System | No data available |
|
Somniton 4.6mg/24hours transdermal patches
0411000E0BIAAAF
|
Somniton | Rivastigmine | Central Nervous System | No data available |
|
Somniton 9.5mg/24hours transdermal patches
0411000E0BIABAG
|
Somniton | Rivastigmine | Central Nervous System | No data available |
|
Sonata 10mg capsules
0401010W0BBABAB
|
Sonata | Zaleplon | Central Nervous System | No data available |
|
Sonata 5mg capsules
0401010W0BBAAAA
|
Sonata | Zaleplon | Central Nervous System | No data available |
|
Sootheze Six Plus 250mg/5ml oral suspension
0407010H0CQAABG
|
Sootheze | Paracetamol | Central Nervous System | No data available |
|
Stelazine 10mg Spansules
0402010X0BBADAB
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stelazine 15mg Spansules
0402010X0BBAEAC
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stelazine 1mg tablets (Imported)
0402010X0BBAKAH
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
|
Stelazine 1mg tablets (Mercury Pharma)
0402010X0BBAAAH
|
Stelazine | Trifluoperazine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.